Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01098630 · ClinicalTrials.gov registry record
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
A clinical trial, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- 778
- Enrollment target
NCT01098630: Completed study, sponsored by Gynecologic Oncology Group.
NCT01098630 is a clinical trial that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 778 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01098630 has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- 778 participants
- Enrollment target
Study Summary
This clinical trial is studying patient, physician, and nurse factors associated with entry onto clinical trials and finishing treatment in patients with primary or recurrent uterine, endometrial, or cervical cancer. Determining how patients make decisions about participating in a clinical trial may help doctors plan clinical trials in which more patients are willing to participate and are satisfied with their decision to participate.
Primary Outcome
Two-sided Mann-Whitney U-tests will be performed.
Interventions
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 778 participants |
| Start Date | 2010-07 |
| Est. Completion | 2018-01-27 |
What the finished NCT01098630 record still lists
NCT01098630 is an observational study that tracks outcomes without assigning an intervention. The registered 778 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT01098630 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01098630 about?
NCT01098630 is a clinical study titled "Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer". This clinical trial is studying patient, physician, and nurse factors associated with entry onto clinical trials and finishing treatment in patients with primary or recurrent uterine, endometrial, or cervical cancer. Determining how patients make decisions about participating in a clinical trial may...
What is the current status of trial NCT01098630?
This trial is currently completed. The enrollment target is 778 participants. The study started on 2010-07. Estimated completion is 2018-01-27.
What interventions are being tested in trial NCT01098630?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT01098630?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06841679 · 778 participants · Phase 2
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT05642611 · 777 participants · Phase 3
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia